PHAT
Phathom Pharmaceuticals Inc.
$13.55
+$0.24(+1.80%)
55
Overall
40
Value
91
Tech
36
Quality
Market Cap
$960.58M
Volume
1.44M
52W Range
$2.21 - $19.50
Target Price
$21.38
Key Metrics Overview
| Market Cap | $960.58M | P/E Ratio | N/A |
| 52W High | $19.50 | 52W Low | $2.21 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -10.8% | 52W Position | 65.6% |
| Overall Score | 55 | Value Score | 40 |
| Quality Score | 36 | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-2.7 | EPS Next Est | $0.53 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHAT | $13.55 | +1.8% | 1.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phathom Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW